[go: up one dir, main page]

ES8707729A1 - Un procedimiento para la preparacion de hexahidroarilquinolizinas sustituidas. - Google Patents

Un procedimiento para la preparacion de hexahidroarilquinolizinas sustituidas.

Info

Publication number
ES8707729A1
ES8707729A1 ES555670A ES555670A ES8707729A1 ES 8707729 A1 ES8707729 A1 ES 8707729A1 ES 555670 A ES555670 A ES 555670A ES 555670 A ES555670 A ES 555670A ES 8707729 A1 ES8707729 A1 ES 8707729A1
Authority
ES
Spain
Prior art keywords
procedure
formula
hexahidroarilquinolizinas
substituted
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES555670A
Other languages
English (en)
Other versions
ES555670A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES555670A0 publication Critical patent/ES555670A0/es
Publication of ES8707729A1 publication Critical patent/ES8707729A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/20Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D455/00Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/22Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/22Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/22Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR HEXAHIDROARILQUINOLIZINAS SUSTITUIDAS. COMPRENDE: A) TRATAR A UN COMPUESTO DE FORMULA (II) CON CARBONILDIIMIDAZOL, EN BENCENO, ENTRE 10 Y 50JC Y B) ALQUILER AL COMPUESTO RESULTANTE DE A) PARA OBTENER UN COMPUESTO DE FORMULA (I). SIENDO: AR HETEROCICLO AROMATICO SELECCIONADO ENTRE R1, R2-BENZO (B) FURO, TIENO-Y FURO-; B UN ESPIRO-HETEROCICLO DE FORMULA (III); R H O ALQUILO DE C 1 A 3; R1 Y R2 H, HAL ALCOXI Y OTROS; R3 H, -COR, ALQUILO DE C 1 A 6 Y OTROS Y R5 H ALQUILO DE 1 A 6 Y OTROS. SE UTILIZAN CONTRA LA OBESIDAD Y COMO ANTIDIABETICAS.
ES555670A 1985-06-03 1986-06-03 Un procedimiento para la preparacion de hexahidroarilquinolizinas sustituidas. Expired ES8707729A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74060985A 1985-06-03 1985-06-03

Publications (2)

Publication Number Publication Date
ES555670A0 ES555670A0 (es) 1987-08-16
ES8707729A1 true ES8707729A1 (es) 1987-08-16

Family

ID=24977288

Family Applications (1)

Application Number Title Priority Date Filing Date
ES555670A Expired ES8707729A1 (es) 1985-06-03 1986-06-03 Un procedimiento para la preparacion de hexahidroarilquinolizinas sustituidas.

Country Status (11)

Country Link
EP (1) EP0204254A3 (es)
JP (1) JPS6236380A (es)
KR (1) KR900004588B1 (es)
AU (1) AU576962B2 (es)
DK (1) DK258086A (es)
ES (1) ES8707729A1 (es)
GR (1) GR861403B (es)
IL (1) IL78918A (es)
NZ (1) NZ216283A (es)
PT (1) PT82643B (es)
ZA (1) ZA864096B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ221485A (en) * 1986-08-28 1991-04-26 Merck & Co Inc Hexahydroarylquinolizine derivatives and pharmaceutical compositions
US4831035A (en) * 1986-08-28 1989-05-16 Merck & Co., Inc. Substituted hexahydroarylquinolizines
CA1321751C (en) * 1989-02-21 1993-08-31 Eugene C. Crichlow Mechanism mediating ruminal stasis in ruminal lactic acidosis
EP1490361B1 (en) 2002-04-03 2007-10-03 Orion Corporation Polycyclic compounds as potent alpha2-adrenoceptor antagonists
CR20240504A (es) 2022-05-17 2024-12-18 Lilly Co Eli Antagonistas de at2r y usos de estos

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1524953A (fr) * 1962-03-26 1968-05-17 Konink Pharmaceutische Fabrike Procédé de préparation des dérivés de la quinolizine

Also Published As

Publication number Publication date
DK258086A (da) 1987-02-20
ES555670A0 (es) 1987-08-16
IL78918A (en) 1990-06-10
KR900004588B1 (ko) 1990-06-30
DK258086D0 (da) 1986-06-02
EP0204254A2 (en) 1986-12-10
KR870000331A (ko) 1987-02-17
AU5826086A (en) 1986-12-11
IL78918A0 (en) 1986-09-30
ZA864096B (en) 1987-01-28
NZ216283A (en) 1989-10-27
EP0204254A3 (en) 1988-03-02
PT82643A (en) 1986-06-01
AU576962B2 (en) 1988-09-08
PT82643B (pt) 1988-03-03
JPS6236380A (ja) 1987-02-17
GR861403B (en) 1986-09-26

Similar Documents

Publication Publication Date Title
EG15458A (en) Improvements in or relating to 3-aryloxy-3-phenylpropylamines
KR860004882A (ko) 항 알레르기제로서 유용한 신규의 산성 인돌화합물 및 그 제조방법
MY103850A (en) Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them.
ES8708235A1 (es) Un procedimiento para la preparacion de derivados de androstendiona 4-sustituida
ES2038188T3 (es) Un procedimiento para preparar nuevas tienopiridinonas.
ES552796A0 (es) Un procedimiento para la preparacion de nuevos derivados de ciclopenta (d) pirimidina.
ES525786A0 (es) Un procedimiento para preparar derivados de pirazolo (3,4-b) piridina
ES8609204A1 (es) Procedimiento de preparar derivados aminicos
ES8606297A1 (es) Procedimiento para preparar (2-oxo-1,2,3,5-tetrahidroimidazo(2,1-b) quinazolinil)-oxialquilamidas
ES8707729A1 (es) Un procedimiento para la preparacion de hexahidroarilquinolizinas sustituidas.
ES8203916A1 (es) Procedimiento para preparar n6-adenosina
ES8708240A1 (es) Un procedimiento para la preparacion de nuevos compuestos poliprenilicos
IT1188838B (it) Procedimento per l'alchilazione di composti fenolici per produrre fenoli orto- e para-monoalchialti e fenoli 2,4- e 2,6-dialchilati
DE3572814D1 (en) 1, 3-benzoxathiole derivatives, their use and their preparation
ES2040226T3 (es) Procedimiento para preparar nuevos tetrahidro-benzotiazoles.
ES8703433A1 (es) Un procedimiento para preparar un derivado triciclico de pi-ridazinona
ES2045282T3 (es) Un procedimiento para la preparacion de antraciclinona 4-sustituida.
IT1210926B (it) Derivati della 1-metil-5-nitro-imidazolina e composizioni terapeutiche che li comprendono come principio attivo.
ES550742A0 (es) Un procedimiento para la preparacion de una octahidroindo- lizina
NO870423L (no) 5-substituerte oktahydroindolizin-analgetiske forbindelser og 7-keto mellomprodukter.
HUT40651A (en) New pharmaceutical composition
ZA842423B (en) Compounds with antiinflammatory activity,process for preparation thereof and pharmaceutical compositions therefrom
MY103572A (en) 3,4-dihydro-2-alkyl-3-oxo-n-aryl-2h-[1] benzothieno [3,2-e]-1,2-thiazine-4-carboxamide-1, 1-dioxides.
ZA906446B (en) Therapeutic agents for the treatment of peptic ulcer disease
ES2038185T3 (es) Procedimiento para preparar inhibidores de dopamina-beta-hidroxilasa.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20000503